StockData
Natera, Inc. logo

Natera, Inc. (NTRA) stock

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30139% above fair value
$287.47−1.01 (-0.35%)

Close on Nov 17, 2026Market cap $41.44BP/E –Yield –

Natera r&d expenses

Research and development expenses are spending on new products and technology.

Natera's R&D Expenses for the twelve months ending Jun 30, 2026 was $787.38M, up 56.9% year over year. For fiscal 2025 it was $624.11M, up 54.4% from the year before. Over ten years it grew 36.5% a year on average. The highest annual figure on record is $624.11M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$624.11M+54.4%
FY2024Dec 31, 2024$404.14M+26.0%
FY2023Dec 31, 2023$320.68M+1.3%
FY2022Dec 31, 2022$316.42M+19.8%
FY2021Dec 31, 2021$264.21M+164.1%
FY2020Dec 31, 2020$100.04M+94.8%
FY2019Dec 31, 2019$51.36M+0.0%
FY2018Dec 31, 2018$51.36M+2.6%
FY2017Dec 31, 2017$50.06M+19.6%
FY2016Dec 31, 2016$41.86M+51.1%
FY2015Dec 31, 2015$27.71M+60.3%
FY2014Dec 31, 2014$17.29M+49.7%
FY2013Dec 31, 2013$11.55M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$228.07M+55.8%
Q1 FY2026Mar 31, 2026$210.70M+63.2%
Q4 FY2025Dec 31, 2025$175.19M+35.3%
Q3 FY2025Sep 30, 2025$173.41M+78.9%
Q2 FY2025Jun 30, 2025$146.43M+64.3%
Q1 FY2025Mar 31, 2025$129.08M+45.6%
Q4 FY2024Dec 31, 2024$129.46M+56.0%
Q3 FY2024Sep 30, 2024$96.93M+25.5%
Q2 FY2024Jun 30, 2024$89.11M+14.0%
Q1 FY2024Mar 31, 2024$88.64M+7.7%
Q4 FY2023Dec 31, 2023$82.96M-5.6%
Q3 FY2023Sep 30, 2023$77.24M+17.9%
Q2 FY2023Jun 30, 2023$78.17M-5.3%
Q1 FY2023Mar 31, 2023$82.31M+2.4%
Q4 FY2022Dec 31, 2022$87.91M+22.4%
Q3 FY2022Sep 30, 2022$65.51M-33.5%
Q2 FY2022Jun 30, 2022$82.58M+53.6%
Q1 FY2022Mar 31, 2022$80.41M+100.1%
Q4 FY2021Dec 31, 2021$71.81M+121.7%
Q3 FY2021Sep 30, 2021$98.46M+272.6%
Q2 FY2021Jun 30, 2021$53.75M+133.7%
Q1 FY2021Mar 31, 2021$40.19M+120.5%
Q4 FY2020Dec 31, 2020$32.38M+115.9%
Q3 FY2020Sep 30, 2020$26.42M+106.5%
Q2 FY2020Jun 30, 2020$23.01M+89.7%
Q1 FY2020Mar 31, 2020$18.23M+59.4%
Q4 FY2019Dec 31, 2019$15.00M+17.5%
Q3 FY2019Sep 30, 2019$12.80M+3.3%
Q2 FY2019Jun 30, 2019$12.12M+2.3%
Q1 FY2019Mar 31, 2019$11.44M-20.3%
Q4 FY2018Dec 31, 2018$12.77M-1.9%
Q3 FY2018Sep 30, 2018$12.39M-1.7%
Q2 FY2018Jun 30, 2018$11.85M+0.6%
Q1 FY2018Mar 31, 2018$14.34M+13.4%
Q4 FY2017Dec 31, 2017$13.02M+13.6%
Q3 FY2017Sep 30, 2017$12.61M+11.1%
Q2 FY2017Jun 30, 2017$11.79M–
Q1 FY2017Mar 31, 2017$12.65M–
Q4 FY2016Dec 31, 2016$11.46M–
Q3 FY2016Sep 30, 2016$11.35M–

More Natera figures

See a number that looks wrong?